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Heart failure is one of the leading causes of high morbidity and mortality. Acute exacerbation 
of heart failure may result in acute respiratory failure, which requires mechanical ventilator 
support. Despite supportive management, patients can fail extubation of the endotracheal 
tube and need a tracheostomy to continue mechanical ventilator support. However, optimal 
timing of tracheostomy has been controversial. Systemic study to assess the clinical and 
economic outcome of early tracheostomy among patients with acute heart failure 
exacerbation is lacking. The purpose of the study was to assess the national trend of 
tracheostomy among those who are admitted for acute respiratory failure with acute 
congestive heart failure exacerbation and to compare clinical and economic outcomes 
between the two groups (early and late tracheostomy) using national discharge data between 
from 2005 to 2014. We also conducted an economic evaluation comparing early and late 
tracheostomy among them using average cost and incremental costs with an outcome of 
length of stay. Among those who are admitted with acute heart failure exacerbation, 0.30% 
patients underwent the tracheostomy, and among them, 9.69% received early tracheostomy. 
There was no trend in the percentage of early tracheostomy. The length of stay in the hospital 
has decreased over time in late tracheostomy group, but it was stable in early tracheostomy 
group. Median total hospital length of stay (19 days) and total hospital cost ($52,158.23) in 
early tracheostomy group were significantly lower than late tracheostomy group (25 days and 
$68,037.40). Patients with coronary artery disease, pneumonia, and liver disease are less 
likely to receive early tracheostomy (OR 0.79, 0.63 and 0.64 respectively). After propensity 
score matching, it showed that the two groups did not show a significant difference in in-
hospital mortality (OR 0.91, p-value 0.676), or decannulation rate (OR 2.01, p-value 0.571). 
However, early tracheostomy was associated with higher likelihood of having a complication 
from tracheostomy with OR 2.08 (p-value 0.044) but was also associated with lower total 
hospital length of stay with coefficient factor -6.50 (p-value 0.000) from the linear regression 
model. From the economic evaluation, the early tracheostomy dominates the late 
tracheostomy with the outcome of total hospital length of stay and post-procedural length of 
stay with lower cost and higher effectiveness. The incremental cost-effectiveness ratio 
(ICER) is negative, meaning it costs $3,492.65 for each additional day in the hospital for late 
tracheostomy compared to early tracheostomy. ICER with the outcome of post-procedural 
length of stay was again negative, showing $2,032.67 per extra day in the hospital after the 
procedure among late tracheostomy group. Early tracheostomy among patients with acute 
heart failure exacerbation had no significant difference in mortality but had significant 
economic benefit with lower cost and less total hospital length of stay.  
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BACKGROUND 
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data 
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was 
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That 
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8 
million people older than 18 years of age with heart failure. 1  One in nine deaths has heart 
failure on the death certificates, according to the National Center for Health Statistics in 
2013. 2  Acute exacerbation of heart failure may result in acute respiratory failure, which 
requires mechanical ventilator support. Despite supportive management, patients can fail 
extubation of the endotracheal tube and need a tracheostomy to continue mechanical 
ventilator support.   
Tracheostomy usually is done to minimize the mechanical trauma to the larynx or trachea, 
facilitate the weaning process, or protect the airway for a long time. Predictors of 
tracheostomy have been mostly reported among trauma or surgical patients, but it has not 
been studied among patients with acute respiratory failure from acute heart failure 
exacerbation. Also, there has not been a systemic study to assess the optimal timing of 
tracheostomy among them. Studies have shown that early tracheostomy reduces the hospital 
stay without clinical outcome difference. 
Literature Review 
• Background 
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Heart failure is one of the leading causes of high morbidity and mortality. Based on the data 
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was 
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That 
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8 
million people older than 18 years of age with heart failure. 1  One in nine deaths has heart 
failure on the death certificates, according to the National Center for Health Statistics in 
2013. 2  Data from Framingham Heart Study indicated that its incidence reached 10 per 1000 
population after the age of 65. 3  Even though overall mortality from cardiovascular disease 
has declined, heart failure is the only major cardiovascular disease whose prevalence and 
incidence is still increasing with poor long term-prognosis. 4-6  Approximately half of the 
people who were diagnosed with heart failure die within 5 years. 7   
• The burden of heart failure 
Considering the development and implementation of life-prolonging interventions along with 
the growing elderly population, the number of individuals with heart failure will be 
significantly increased, which will also increase the cost of heart failure. 7,8  In 2012, the 
estimate of heart failure related direct cost was $20.9 billion, and the indirect cost was $9.80 
billion. 4,7  By 2030, it is anticipated that the total cost will increase to $69.7 billion which 
will equal $244 for every United States adult. Costs of heart failure are mainly driven by 
hospitalization, home nursing, hospice care, medical devices including cardiac 
resynchronization, ventricular assist device, and transplantation. 8  A study using 10-year data 
from the National Medical Expenditure Panel Survey (2002-2011) showed that individuals 
with heart failure had 4 times higher yearly expenditure ($23,854)  compared to those 
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without heart failure ($5,511). Heart failure-related costs increased by $5,836 (28% relative 
increase), from $21,316 in 2002 to $27,152 in 2010. The single largest driving component of 
this increase was inpatient costs ($11,318). 8   
• Acute respiratory failure due to acute congestive heart failure exacerbation 
Acute congestive heart failure is a common but potentially fatal condition, caused by 
congestive heart failure and may result in acute respiratory failure. It is characterized by 
acute dyspnea caused by acute fluid accumulation in the lungs. Most of the times, it is caused 
by a rapid increase in hydrostatic pressure in the pulmonary capillaries due to elevated 
cardiac filling pressure. This condition is also called cardiogenic pulmonary edema. 9  In 
treating patients with acute congestive heart failure exacerbation, routine oxygen 
supplementation is not indicated, but if the patient demonstrates hypoxemia (SpO2 <90%), 
oxygen supplementation should be initiated. 10  If the patient still shows respiratory distress, 
the patient will need assisted ventilation. First line treatment is a trial of noninvasive 
ventilation. However, if noninvasive ventilation is contraindicated or patient fails to improve 
with noninvasive ventilation within 1-2 hours, the patient should be intubated for 
conventional mechanical ventilation. 
• Mechanical ventilation for treatment of respiratory failure 
A mechanical ventilator is a machine, which assists or replaces the patient’s spontaneous 
breathing using positive pressure. Mechanical ventilation for respiratory failure due to 
congestive heart failure exacerbation is usually initiated to reverse life-threatening 
hypoxemia (low oxygen level in blood), to provide sufficient oxygen delivery to vital organs, 
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to maintain alveolar stability, and to decrease the work of breath to prevent respiratory 
muscle fatigue. 11,12 For the patient to receive mechanical ventilation, the patient should have 
a special form of a device, which allows the patient's airway to be directly connected to the 
mechanical ventilator. Usually, this special airway is achieved through the procedure 
"endotracheal intubation" in an emergent situation. Endotracheal intubation is a procedure to 
place a plastic tube in the patient's trachea, which can be connected to the mechanical 
ventilator to make a circuit for mechanical ventilation. 13  (Figure 1) The tube may be made of 
rubber or plastic and usually has a balloon cuff to keep the tube in place and closed system 
with the ventilator.  
Figure 1. Endotracheal intubation 
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• The role of tracheostomy 
Despite ongoing treatment for congestive heart failure, not all the patients can be weaned off 
the ventilator. In such cases, the health care providers should consider tracheostomy. 11,14  
(Figure 2) Tracheostomy is a procedure to make an external artificial opening to the trachea. 
It could be done as a traditional surgical procedure in an operating room, or it also could be 
done at the bedside using percutaneous method. 15-19  Tracheostomy is considered to be 
beneficial among the patients who need prolonged mechanical ventilation, as it is thought to 
be more comfortable for the patients, requires less sedation, and provides more stable airway 
compared to an endotracheal tube. 11  However, tracheostomy does carry several 
complications, such as bleeding, cardiopulmonary arrest, hypoxia, structural damage, 
pneumothorax, pneumomediastinum, infection, tracheal stenosis, granulation and erosion of 
the innominate artery. 11  Hence, the optimal time for tracheostomy with the goal of getting 
extubated, and also to prevent complications from prolonged intubation and to secure more 
stable airway, has been controversial. 15,20  However, tracheostomy is typically done between 
10th and 14th days of intubation. 15,21  Also, there is no clear definition when is “early” 
tracheostomy or “late” tracheostomy.  Moreover, there is also no clear evidence supporting 
the optimal timing of tracheostomy. 22-24  However, some studies have shown a benefit of 
early tracheostomy with shorter hospital stays, shorter length of stay in the intensive care 
unit, and shorter duration of mechanical ventilation. However, benefit in overall mortality is 
still controversial. 25-28  Furthermore, most of the studies comparing early and late 
tracheostomy are done among trauma patients or excluded certain underlying respiratory 
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conditions. A specific study investigating the optimal timing for patients with respiratory 
failure due to congestive heart failure acute exacerbation is lacking.  
Figure 2. Tracheostomy  14  
,  
 
• Comparison early and late tracheostomy 
Several studies are comparing early and late tracheostomy to assess various outcomes, but 
those studies have shown inconsistent outcomes, or their outcomes do not provide strong 
evidence due to heterogeneity of the study populations and outcome variables. 15,21-24,26,29-41  
Most of the studies focus on trauma patients or were conducted at surgical care unit, 21-
26,29,35,36,38-40,42  and several studies have included critically ill medical patients. 33,34,37,40,41  
Furthermore, those studies included patients with various reasons for intubation. 15,30,31,34,40   
Most recently, Andriolo et al. published a systematic review comparing early and late 
tracheostomy in critically ill patients. 15  However, they reported mortality result from 
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individual studies rather than reporting the result from the review, because of the 
inconsistency and the possibility of substantial statistical heterogeneity among the studies. 
Rumbak et al. conducted a prospective randomized trial comparing early and late 
tracheostomy among patients in a medical intensive care unit, and reported a significant 
mortality benefit (31.7% vs. 61,7%) and less pneumonia (5% vs. 25%), for the early cohort. 
37  Young et al. also conducted a randomized control clinical trial comparing early and late 
tracheostomy, but there was no significant difference in mortality (30.8% vs. 31.5%). 33  
From another randomized controlled trial, Zheng et al. also reported no significant difference 
in mortality between the two groups. 32  Studies have also used various clinical outcome 
variables. For example, Terragni et al. used outcome as prevention of ventilator-associated 
pneumonia and found out that early tracheostomy did not result in significant improvement 
in preventing ventilator-associated pneumonia. 34  Young et al. also included several 
outcomes in the systematic review, other than 30-day mortality, such as two-year mortality, 
medical intensive care unit length of stay and tracheostomy-related complications. 33  Several 
studies are comparing the duration of mechanical ventilation, and most of them reported a 
shorter duration of mechanical ventilation among early tracheostomy groups, but with mixed 
statistical significance. 32-34,37  
Public Health Significance 
Considering the significant economic burden of acute heart failure exacerbation and 
subsequent respiratory failure requiring intubation, an optimal strategy to manage those 
patients should be investigated. Liu et al. reported cost-effectiveness of early versus late 
tracheostomy with the outcome of tracheostomy prevented and it showed that early 
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tracheostomy could be more cost-effective with a willingness to pay threshold of $80,000 per 
tracheostomy avoided. 30  Other studies have shown that early tracheostomy may provide less 
mortality and fewer healthcare resources utilization. However, most of the studies included 
heterogeneous clinical conditions in their outcome assessment. Furthermore, to the best of 
our knowledge, studies comparing early and late tracheostomy for patients with acute 
respiratory failure due to congestive heart failure are lacking. The result of the study will 
provide evidence to assist both clinicians and hospital administrator in determining the most 
efficient care strategy for managing patients with respiratory failure from acute heart failure 
exacerbation requiring ventilator assistance. 
Hypothesis, Research Question, Specific Aims or Objectives 
The purpose of the study is to assess the national trend of tracheostomy among those who are 
admitted for acute respiratory failure with acute congestive heart failure exacerbation and to 
compare clinical and economic outcomes between the two groups (early and late 
tracheostomy) using propensity score matching. Lastly, we will conduct an economic 
evaluation comparing early and late tracheostomy among them using average and 
incremental costs with an outcome of length of stay.  
• Objectives  
o Aim 1. To identify the national trend of tracheostomy among those who 
developed respiratory failure with acute congestive heart failure exacerbation.  
§ Trend of tracheostomy use– early (<7 days) vs. late (≥7 days) 
§ Identify the predictors of tracheostomy – early vs. late 
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o Aim 2: Compare the two groups (early vs. late) in outcomes – in-hospital 
mortality, total hospital length of stay and total hospital cost. 
o Aim 3: Economic evaluation of early and late tracheostomy among those who 
developed respiratory failure with acute congestive heart failure exacerbation- 
average and incremental costs with outcome of total hospital length of stay, 
and post-procedural length of stay. 
METHODS 
Conceptual Model 
We used the conceptual model for health service research, introduced by Begley et al. (Table 
1). 43  This conceptual model provides frameworks and methods for assessing health services 
and system with the three objectives: effectiveness, efficiency, and equity. Effectiveness 
evaluates the intended and desired outcomes by the health services, such as mortality or life 
expectancy, but is not limited to health outcome but also includes the impact of health 
outcomes such as quality of life or well-being. The second objective, efficiency, is to monitor 
and assess both production efficiency and allocative efficiency of a certain health care 
service. It evaluates the health care service whether it maximized the performance with the 
minimum cost with an optimal combination of investments. Equity focuses on distributional 
fairness in the delivery of the health service. Eventually, those three objectives provide the 
criteria for evaluating the health services overall performances. This study's each goal fits 
each perspective of health service research as below. (Table 2)   
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Table 1. Definitions of Effectiveness, Efficiency, and Equity Criteria 
Criteria 
Level of analysis 
Clinical Population 
Effectiveness 
Clinical effectiveness: Improving 
the health of individual patients 
through the delivery of healthcare 
services 
Population effectiveness: 
Improving the health of 
populations through medical or 
nonmedical services 
Efficiency 
Production efficiency: Combining 
inputs to produce services at the 
lowest cost 
Production efficiency: combining 
inputs to produce services at the 
lowest cost 
Allocative efficiency: Combining 
health services and other health-
related investments to produce 
maximum health given available 
resources 
Equity 
Procedural equity: Maximizing the 
fairness in the distribution of 
services across individuals  
Substantive equity: Minimizing 
the disparities in the distribution 
of health across individuals 
Procedural equity: Maximizing the 
fairness in the distribution of 
services across groups 
Substantive equity: Minimizing 
the disparities in the distribution 
of health across groups 
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Table 2. Conceptual model for each aim in this study 
 
Usually, these three perspectives are assessed in clinical and population level (Table 1). At 
the clinical level, the analysis focuses on personal health care resources, such as technology, 
expertise, equipment, and facilities. Outcomes are usually measured at a personal level. At 
the population level, the analysis focuses on the improvement of population health. In this 
study, we will focus on clinical analysis since the analysis will be done at an individual level.   
Criteria 
Level of analysis 
Clinical Aim 
Effectiveness 
Clinical effectiveness: Improving 
the health of individual patients 
through the delivery of healthcare 
services 
Aim 2. Compare the two groups 
(early vs. late) in outcomes –  in-
hospital mortality, length of stay, 
and total hospital cost 
Efficiency 
Production efficiency: Combining 
inputs to produce services at the 
lowest cost 
Aim 3. Economic evaluation of 
early and late tracheostomy 
among those who developed 
respiratory failure with acute 
congestive heart failure 
exacerbation- average and 
incremental costs with outcome 
of total hospital length of stay, 
and post-procedural length of 
stay. 
Equity 
Procedural equity: Maximizing 
the fairness in the distribution of 
services across individuals  
Substantive equity: Minimizing 
the disparities in the distribution 
of health across individuals 
Aim 1. C. Predictors of early and 
late tracheostomy will be 
evaluated by multivariate logistic 
regression.  
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ABSTRACT 
Background 
Acute exacerbation of heart failure may result in acute respiratory failure, requiring 
endotracheal intubation. For those who fail extubation, tracheostomy is indicated. However, 
the optimal timing of tracheostomy among patients with acute heart failure exacerbation has 
not been determined, despite multiple studies assessing the utility of early tracheostomy. 
Furthermore, there is no study evaluating the benefit of early tracheostomy among patients 
who are admitted with acute heart failure exacerbation.  
Methods 
We conducted a retrospective cohort study using National Inpatient Sample data from 2005 
to 2014 to assess the trend of utilization and outcome of early tracheostomy among patients 
with acute heart failure exacerbation.  
Results 
Among those who are admitted with acute heart failure exacerbation, 0.30% patients 
underwent the tracheostomy, and among them, 9.69% received early tracheostomy. There 
was no significant trend in the percentage of early tracheostomy. The length of stay in the 
hospital has decreased over time in late tracheostomy group, but it was stable in early 
tracheostomy group. Median total hospital length of stay (19 days) and total hospital cost 
($52,158.23) in early tracheostomy group were significantly lower than late tracheostomy 
group (25 days and $68,037.40).  
Conclusion 
	 20	
Early tracheostomy has been used in 9.69% of the patients who underwent tracheostomy with 
heart failure acute exacerbation in the United States from 2005 to 2014 without any trend in 
utilization. Early tracheostomy is associated with lower hospital length of stay and costs.  
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INTRODUCTION 
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data 
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was 
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That 
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8 
million people older than 18 years of age with heart failure. 1  Acute heart failure 
exacerbation is a common but potentially fatal condition which may result in acute 
respiratory failure. Once developed, the patient will need assisted ventilation. First line 
treatment is a trial of noninvasive ventilation. However, if noninvasive ventilation is 
contraindicated or patient fails to improve with noninvasive ventilation within 1-2 hours, the 
patient should be intubated for mechanical ventilation. Despite ongoing treatment, not all the 
patients can be weaned off the ventilator. In such cases, tracheostomy is indicated. 11,14  
Tracheostomy is considered to be beneficial among the patients who need prolonged 
mechanical ventilation, as it is thought to be more comfortable for the patients, requires less 
sedation, and provides more stable airway compared to an endotracheal tube. 11  However, 
tracheostomy carries several complications, such as bleeding, cardiopulmonary arrest, 
hypoxia, structural damage, pneumothorax, pneumomediastinum, infection, tracheal stenosis, 
granulation and erosion of the innominate artery. 11  Hence, the optimal time for tracheostomy 
with the goal of getting extubated, and also to prevent complications from prolonged 
intubation and to secure more stable airway, has been studied. 15,20  Some studies have shown 
a benefit of early tracheostomy with shorter length of stay in the intensive care unit and 
shorter duration of mechanical ventilation. However, benefit in overall mortality is still 
controversial. 25-28  Furthermore, most of the studies comparing early and late tracheostomy 
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are done among trauma patients or excluded certain underlying respiratory conditions. A 
specific study investigating the utilization of early tracheostomy for patients with respiratory 
failure due to congestive heart failure acute exacerbation is lacking. The purpose of the study 
is to assess the national trend in utilization of early tracheostomy among those who are 
admitted for acute respiratory failure with acute congestive heart failure exacerbation and 
assess its outcomes. 
METHODS 
Study subjects 
We conducted a retrospective cohort study using publically accessible national survey data, 
National Inpatient Sample (NIS) from 2005 to 2014. NIS is the largest all-payer inpatient 
care database in the United States, which is developed by the Healthcare Cost and Utilization 
Project (HCUP) 44  NIS is designed to be representative of all non-federal acute care inpatient 
admissions in the United States. It contains both patient and hospital information. NIS can 
approximate a 20 percent stratified sample of discharges nationwide. From the NIS dataset, 
patients who are older than 17 were included for the current study. Then, patients who were 
admitted with acute heart failure were selected using the International Classification of 
Diseases Ninth Revision, Clinical Modification (ICD-9-CM) code. NIS data provides total 30 
ICD-9-CM codes. If any of the codes for “acute” heart failure, 428.21 (acute systolic health 
failure), 428.23 (acute on chronic systolic heart failure), 428.31 (acute diastolic heart failure), 
428.33 (acute on chronic diastolic heart failure), 428.41 (acute combined systolic and 
diastolic heart failure) and 428.43 (acute on chronic combined systolic and diastolic heart 
failure) was listed in the first five diagnosis codes, that visit was considered as heart failure 
	 23	
acute exacerbation related admission.  We used the first five diagnosis codes out of thirty 
diagnosis codes, since the diagnosis codes already had "acute" components in the diagnosis, 
and tried to minimize the chances of missing samples. Then, patients who underwent 
intubation were selected using ICD-9-CM codes, 96.04 (Insertion of the endotracheal tube) 
and 96.05 (other intubation of respiratory tract). Also, if the patient had any of the code for 
"tracheostomy," 31.1 (temporary tracheostomy), 31.2 (permanent tracheostomy), 31.21 
(mediastinal tracheostomy) or 31.29 (other permanent tracheostomy) among the 15 
procedural codes, then the case was selected. Early tracheostomy was defined if the 
tracheostomy was performed in less than 7 days after intubation. Those who underwent 
“major therapeutic surgery” based on the classification from HCUP were excluded, 45   
Statistical Analysis 
First, the nationally representative estimated number of tracheostomy was evaluated using 
discharge weight (variable DISCWT), provided by AHRQ 46-48 . By using this weight, NIS 
allows the researchers to obtain the national estimate for the variable interested. Then, age-
adjusted percentages of each procedure were also plotted over time. A Cochran-Armitage test 
was used to assess the trend of the percentage of tracheostomy and early tracheostomy. 
Trends of the days between the intubation and the tracheostomy, total length of stay in the 
hospital and total hospital cost over time were also assessed using linear regression test. All 
the costs were calculated from the total hospital charges using an adjustment factor from the 
provided by AHRQ. 49  Then, the costs were again adjusted to 2014 currency using consumer 
price index.  
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Then, the days between the intubation and the tracheostomy, total hospital costs, and total 
hospital length of stay were compared between the two groups (early and late tracheostomy) 
using a propensity score matching. Propensity score matching is a statistical method allowing 
an observational study to estimate the effect of an intervention by controlling the covariates 
in a way analogous to a randomized trial. 50,51  In this study, we used nearest neighbor 1:1 
matching method using the propensity score of being assigned to early tracheostomy to 
identify a matched pair. Co-variables to be used to calculate the propensity score are age, sex, 
race, payers, location of the hospital (urban vs. rural) and comorbidities (coronary arterial 
disease, hypertension, cerebrovascular disease, diabetes mellitus, peripheral arterial disease, 
chronic obstructive pulmonary disease, cancer, liver disease, pneumonia). Comorbidities 
were selected from a literature using NIS dataset assessing a cardiologic procedure and 
additional significant systemic disorders. 52  and they were identified using relevant ICD-9 
CM diagnosis code and Clinical Classification Software (CCS) category provided by HCUP 
from the 30 diagnosis codes, which were documented at the time of discharge. 45   
After matching, Mann-Whitney U test was used to compare the outcomes. Since the cost and 
length of stay were not normally distributed, median with the quartiles was reported. 
All analyses were conducted using STATA 14 (College Station, TX). A p-value less than 
0.05 was considered as statistical significance for all tests. 
Sample size calculation 
Various methods for sample size calculation for trend analysis exist. Hyndman and 
Kostenko, and they recommended a minimum 6 observations for yearly trend analysis, but 
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Hanke recommended minimum 20 to 60 observations for trend analysis. 53,54  We will use a 
sample size of 60 for trend analysis. 
RESULTS 
From 2005 to 2014, NIS data included total 77,394,755 patients. Among them, total 
64,827,613 patients were more than 17 years old. First, we selected patients who had 
diagnostic codes for acute heart failure exacerbation from the first five diagnostic codes 
(1,623,013 left).  Among them, 214,265 patients underwent major therapeutic surgery during 
the hospitalization, and they were excluded. The 52 cases were excluded due to negative 
values for length of stay and cost. Total 1,408,696 patients were included in the final 
analysis. Figure 1 shows the flow chart selecting the final subjects.   
Trend and percentage of tracheostomy among acute heart failure exacerbation 
Among 1,408,696 eligible patients, 3,698 patients underwent tracheostomy. This is 
approximately 0.30% of the total patients who were admitted with acute heart failure 
exacerbation after adjusted with age. Table 1 shows the observed counts, estimated counts of 
tracheostomy and the percentage of tracheostomy from the estimated counts among patients 
with acute heart failure exacerbation.  
Age distribution tables for each year from the United States Census were used for calculation 
of age-adjusted percentage. 55  The age-adjusted percentage of tracheostomy among acute 
heart failure exacerbation patients using the national estimate counts were 0.35% in 2005, 
0.18% in 2006, 0.30% in 2007, 0.26% in 2008, 0.26% in 2009, 0.33% in 2010, 0.33% in 
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2011, 0.36% in 2012, 0.30% in 2013, and 0.29% in 2014. (Figure 2) The percentage of 
tracheostomy over time from the estimated population was stable over time (p-value 0.9268). 
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Figure 1. Selection of cohort for the final analysis 
 
 
Total	11,394,755	patients	
64,827,613	left	
1,623,013	left	
1,408,748	left	
1,408,696	left	
Age	≤17	12,567,142	excluded	
No	acute	heart	failure	exacerbation		63,204,600	excluded	
Erroneous	negative	value	of	length	of	stay	or	cost	52	excluded	
Major	therapeutic	surgery	214,265	excluded	
3,698	received	tracheostomy	
1,404,998	did	not	receive	tracheostomy	
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Table 1. Age-adjusted percentage of tracheostomy among patients with acute heart failure 
exacerbation 
Year Total Tracheostomy 
 Observed 
counts 
Weighted 
counts 
Observed 
counts (N) 
Weighted 
counts (N)  
Crude 
percentage 
(%) 
Age adjusted 
percentage 
(%) 
2005 13,742 66,713 42 206  0.31 0.35 
2006 13,095 64,675 32 158  0.24  0.18 
2007 25,505 127,682 46 230  0.18  0.30 
2008 110,281 544,485 229 1,129  0.21  0.26 
2009 157.590 799,454 376 1,915  0.24  0.26 
2010 183,254 917,482 530 2,665  0.29  0.33 
2011 221,170 1,063,300 653 3,157  0.30  0.33 
2012 208,637 1,043,185 593 2,965  0.28  0.36 
2013 226,906 1,134,530 571 2,855  0.25  0.30 
2014 248,516 1,242,681 626 3,130  0.25  0.29 
Total 1,408,696 7,004,087 3,698 18,410 0.26 0.30 
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Figure 2.  Age-adjusted percentage of tracheostomy among patients who are admitted for 
acute heart failure exacerbation (%) 
 
Trend and percentage of early tracheostomy among patients who received a tracheostomy 
Among those who underwent the tracheostomy, overall 9.69% received early tracheostomy 
(tracheostomy < 7 days after intubation). The age-adjusted percentage of early tracheostomy 
among those who received tracheostomy during the admission with acute heart failure 
exacerbation was 22.13% in 2005, 3.21% in 2006, 6.47% in 2007, 9.68% in 2008, 5.92% in 
2009,10.61% in 2010, 9.40% in 2011, 10.81% in 2012, 10.57% in 2013 and 8.07% in 2014 
(Table 2 and Figure 3). Due to the low sample size in the year of 2005, 2006 and 2007, they 
were not included in trend analysis. From 2008 to 2014, there was no specific trend in the 
percentage of early tracheostomy (p-value 0.7660). 
0.35	
0.18	 0.30	 0.26	 0.26	
0.33	 0.33	 0.36	 0.30	 0.29	
0.00	0.10	
0.20	0.30	
0.40	0.50	
0.60	0.70	
0.80	0.90	
1.00	
2005	 2006	 2007	 2008	 2009	 2010	 2011	 2012	 2013	 2014	
Age-adjusted	percentage	of	
tracheostomy	
	 30	
 
Table 2. Age-adjusted percentage of early tracheostomy among patients who underwent 
tracheostomy during the admission with acute heart failure exacerbation 
Year Total Early tracheostomy 
 Observed 
counts 
Weighted 
counts 
Observed 
counts (N) 
Weighted 
counts (N)  
Crude 
Percentage 
(%) 
Age-adjusted 
percentage 
(%) 
2008 229 1,129 28 137 12.17 9.68 
2009 376 1,915 35 175 9.15 5.92 
2010 530 2,665 73 365 13.7  10.61 
2011 653 3,157 77 371 11.75 9.40 
2012 593 2,965 78 390 13.15 10.81 
2013 571 2,855 86 430 15.06 10.57 
2014 626 3,130 76 380 12.14 8.07 
Total 3,698 18,410 464 2,301 12.5 9.69 
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Figure 3. Age-adjusted percentage of early tracheostomy among patients who underwent 
tracheostomy during the admission with acute heart failure exacerbation 
 
Trend of tracheostomy day, total hospital length of stay and total hospital cost  
The median length of days between intubation and tracheostomy (tracheostomy day) was 13 
in late tracheostomy group, and it had a trend to decrease over time (p-value 0.025 with 
coefficient factor -0.29). The median tracheostomy day was 4 in early tracheostomy group, 
and there was no specific trend in tracheostomy day (p-value 0.855 and coefficient factor -
0.04). The median total hospital length of stay in late tracheostomy group was 25, and it 
showed a trend to decrease over time (p-value 0.042 with coefficient factor 0.89). The 
median length of stay in the hospital for early tracheostomy was 19, and it has decreased over 
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time (p-value 0.019 with coefficient factor -1.107). Trend analysis for early tracheostomy 
group included years from 2008 to 2014 due to the low sample size in the years from 2005 to 
2007. (Table 3, Figure 4 and Figure 5) 
Table 3. Trend of tracheostomy day and total hospital length of stay between the two groups 
 Tracheostomy day Total hospital length of stay 
 Late 
tracheostomy  
Early 
tracheostomy 
Late 
tracheostomy  
Early 
tracheostomy 
2005 16 3 32 18 
2006 16 5 36 36 
2007 13 0 23 15 
2008 13 3 26 24 
2009 13 4 28 22 
2010 13 5 26 22 
2011 13 5 24 18 
2012 13 3 26 18 
2013 13 3 23 16 
2014 13 4 25 19 
Total 13 4 25 19 
p-value for 
trend 
0.025 0.855* 0.042 0.019* 
Coefficient 
factor 
-0.29 -0.04 -0.89 -1.107 
* Trend analysis in early tracheostomy group includes data from the year 2008 to 2014 
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Figure 4. Tracheostomy day for each group 
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Figure 5. Total hospital length of stay for each group 
 
The median hospital cost was $71,181.13 in late tracheostomy group, and the median 
hospital cost over time significantly decreased from 2005 to 2014 with p-value 0.008 and 
coefficient factor from linear regression model -1,958.49. The median hospital cost in early 
tracheostomy group was $51,573.30, and it also showed a trend to decrease over time p-value 
0.002 with coefficient factor -1,994.71). (Table 4 and Figure 6) 
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Table 4. Trend of total hospital cost in two groups 
 Late tracheostomy ($) Early tracheostomy ($) 
2005 90,755.61 61,847.87 
2006 69,745.03 56,704.20 
2007 80,935.66 49,311.22 
2008 79,784.89 57,244.90 
2009 75,339.24 58,947.73 
2010 73,359.88 54,466.42 
2011 71,027.15 53,242.70 
2012 70,623.30 51,224.91 
2013 66,135.12 46,475.97 
2014 66,525.91 48,022.63 
Total 71,181.13 51,573.30 
p-value for trend 0.008 0.002 
Coefficient factor -1,958.49 -1,994.71 
* Trend analysis in early tracheostomy group include data from year 2008 to 2014 
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Figure 6. Total hospital cost for each group 
	 
Comparison of tracheostomy day, total hospital length of stay and total hospital cost 
between the two groups. 
 After propensity score matching, the matched cohort had 329 cases in each group. Table 5 
shows the characteristics of covariates before and after matching.  
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Table 5. Characteristics of covariates before and after matching 
 Before match After match 
 Early 
tracheostomy 
N=464 
Late 
tracheostomy 
N=3,234 
p-value Early 
tracheostomy 
N=329 
Late 
tracheostomy 
N=329 
p-value 
Age (year) 66.25 66.88 0.342 66.20 66.772 0.537 
Sex (%) 52.37 52.94 0.819 52.24 51.53 0.837 
Non-white (%) 42.96 40.31 0.296 43.29 48.00 0.169 
Non-public 
insurance (%) 
31.47 31.17 0.897 30.82 33.18 0.463 
Urban hospital (%) 84.84 84.24 0.744 85.41 84.24 0.744 
Coronary artery 
disease (%) 
37.50 41.47 0.104 36.94 34.35 0.431 
Hypertension (%) 62.50 57.85 0.058 63.29 60.47 0.397 
Cerebrovascular 
disease (%) 
11.42 8.94 0.084 11.06 11.77 0.747 
Diabetes mellitus 
(%) 
43.89 39.21 0.130 43.29 43.29 >0.99 
Peripheral arterial 
disease (%) 
4.31 5.69 0.224 4.05 4.56 0.605 
Chronic obstructive 
pulmonary disease 
(%) 
40.52 38.06 0.310 40.47 45.65 0.128 
Cancer (%) 12.72 9.83 0.055 12.94 10.82 0.341 
Chronic kidney 
disease (%) 
32.76 33.09 0.889 32.94 32.94 >0.99 
Liver disease (%) 7.76 10,48 0.069 7.294 6.118 0.494 
Pneumonia (%) 5.95 75.51 <0.001 66.59 69.65 0.339 
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The comparison of the outcomes between the early tracheostomy group and late 
tracheostomy group from the matched pair is shown at table 6. The median tracheostomy day 
was significantly longer in late tracheostomy group (12 days), compared to early 
tracheostomy group (4 days) with p-value <0.001. Median total hospital cost was 
significantly higher in late tracheostomy group ($68,037.4) than in early tracheostomy group 
($52,168.23) with p-value <0.001. Median total length of stay in the hospital was 
significantly longer in late tracheostomy group (25 days) than in early tracheostomy group 
(19 days) with p-value <0.001.  
 
Table 6. Comparison of tracheostomy day, total hospital length of stay, and total hospital cost 
from the matched pair 
 Late tracheostomy Early tracheostomy p-value 
Median tracheostomy day 
(days, quartiles) 
12 (9~16) 4 (1~5) <0.001 
Median total hospital cost ($, 
quartiles) 
68,037.4 
(46,949.75~104,730.5) 
52,158.23 
(36,656.73~75,114.96) 
<0.001 
Median length of stay (days, 
quartiles) 
25 (18~36) 19 (13~28) <0.001 
 
DISCUSSION 
The decision when to place a tracheostomy is not a simple procedure, and it is affected by 
various factors, including the patient’s condition, the patient’s preference, the surgeon’s 
preference or the hospital policy. In addition, there is no consensus or guideline for the 
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optimal timing of tracheostomy. Nevertheless, a large body of literatures showed various 
benefits of early tracheostomy in a different clinical setting and in different patient groups.    
However, there is no study assessing the utility of early tracheostomy among patients with 
acute heart failure exacerbation. Current study tried to evaluate the national trends in 
tracheostomy and early tracheostomy among those who are admitted to the hospital with 
acute congestive heart failure exacerbation. We also compared clinical and economic 
outcomes between early tracheostomy group and late tracheostomy group.  
The overall utilization of tracheostomy and early tracheostomy among the study population 
has been stable over time from 2005 to 2014 from our study. There are a couple of studies 
that evaluated the trend of tracheostomy in different study populations, but there is no study 
evaluating the trend of early tracheostomy. Mehta et al. conducted a similar study to assess 
the trend in tracheostomy for mechanically ventilated patients using NIS dataset from 1993 
to 2012. 56  They reported that the utilization of tracheostomy had risen significantly over 
time from 1993 to 2008 and then declined afterward. Chatterjee et al. also reported the trend 
in tracheostomy after stroke using NIS dataset, and concluded that tracheostomy use has 
increased from 1994 to 2013. However, their results cannot be directly compared to ours 
since the study population and the time period are different. 57  
Further in-depth analysis to assess the trends in other parameters of utilization of 
tracheostomy showed that, in late tracheostomy group, the length of days between the 
intubation and tracheostomy (tracheostomy day) decreased from 16 days (in 2005 and 2006) 
to 13 days in 2014. However, after 2007, there is no specific trend, and the tracheostomy day 
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had been 13 until 2014. (Table 3) The median length of stay in the hospital in both group 
decreased over time (from 32 days to 25 days in late tracheostomy group and from 24 days to 
19 days in early tracheostomy group). 
Interestingly, the total hospital cost continued to decrease over time in both late and early 
tracheostomy group. Considering the stable length of stay in both groups, this finding 
suggests that the cost per day in the hospital has declined over time. It is noteworthy that 
other literatures suggest the economic burden of heart failure would increase over time. 1,58  
However this result should be interpreted in the context that our study population was people 
who underwent tracheostomy. We conducted a subanalysis trending total hospital cost for 
acute heart failure exacerbation regardless tracheostomy status, and it showed that the 
hospital cost increased overtime with p-value 0.003 and coefficient factor 63.48. A possible 
explanation could be more efficient care after tracheostomy or decreasing cost of the 
procedure over time. However, given the limited information from the dataset, we could not 
verify such a hypothesis. 
We also compared the days between the intubation and the tracheostomy, total hospital cost 
and total length of stay in the hospital between the two groups using propensity score 
matching. We used propensity score matching to reduce the selection bias. After matching, 
the outcomes were compared, and it did show a significant association of early tracheostomy 
with lower total hospital cost and total length of stay in the hospital.  
The current study holds several limitations. First, this study is a retrospective study using 
discharge data. Even though the data is a nationally representative dataset and we used a 
	 41	
propensity score matching to minimize the confounding effect of other variables, selection 
bias cannot be completely eliminated. Choice of timing for tracheostomy might be affected 
by the clinician's preference, the patient's decision, hospital policy or other co-existing 
clinical conditions that were not captured in this study. Furthermore, the comorbidities were 
identified from the discharge diagnosis code, and it is possible that the comorbidities had not 
existed at the time of the decision of tracheostomy.  
Second, we used first five diagnosis codes, rather than only the first diagnosis, among 30 
diagnosis codes to identify the patients with acute heart failure exacerbation, to minimize the 
chances to miss any case. Additionally, the etiology of respiratory failure requiring intubation 
could be documented in second or third place of the diagnosis list. However, it is also 
possible that the patient might have several clinical conditions to be admitted with respiratory 
failure requiring intubation, such as chronic obstructive pulmonary disease or pneumonia, 
which will make our study group heterogeneous. Furthermore, NIS does not provide 
information regarding the severity of heart failure, which could impact the decision of early 
and late tracheostomy. 
Last, the sample size was fairly small for analysis. We used weight to get a national estimate, 
but still, the sample size for the year of 2005, 2006 and 2007 was not enough for trend 
analysis. Even though we had enough sample size for other years, the fact that they were 
estimated numbers, rather than actual observations is still carries a limitation for this study.  
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CONCLUSION 
From 2005 to 2014, the percentage of early tracheostomy among those who underwent 
tracheostomy with acute heart failure exacerbation had been stable. The length of stay in the 
hospital among those who underwent early tracheostomy had been stable over time, but the 
total hospital cost had been decreased. Early tracheostomy group showed a shorter length of 
stay in the hospital (19 days) and less total hospital cost ($52,158.23) compared to late 
tracheostomy group (25 days and $68,037.4).  
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ABSTRACT 
Background 
Acute exacerbation of heart failure may result in acute respiratory failure, requiring 
endotracheal intubation. For those who fail extubation, tracheostomy is indicated. The utility 
of early tracheostomy has been studied, but not specifically for patients with acute heart 
failure exacerbation.     
Methods 
We conducted a retrospective cohort study using National Inpatient Sample data from 2005 
to 2014 to assess the predictors of early tracheostomy (<7 days after intubation) and compare 
various outcomes between early and late tracheostomy group among patients with acute heart 
failure exacerbation.  
Results 
The result from multivariate logistic regression adjusting covariables (age, sex, insurance, 
hospital location, race, comorbidities) it showed that patients with coronary artery disease, 
pneumonia, and liver disease are less likely to receive early tracheostomy (OR 0.79, 0.63 and 
0.64 respectively). The matched pair was compared after propensity score matching, and it 
showed that the two groups did not show a significant difference in in-hospital mortality (OR 
0.91, p-value 0.676), or decannulation rate (OR 2.01, p-value 0.571). However, early 
tracheostomy was associated with higher likelihood of having a complication from 
tracheostomy with OR 2.08 (p-value 0.044) but was also associated with lower total hospital 
length of stay with coefficient factor -6.50 (p-value 0.000) from linear regression model. 
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Conclusion 
Patients with coronary artery disease, liver disease, and pneumonia were associated lower 
likelihood to receive early tracheostomy (<7 days after intubation) rather than late 
tracheostomy among patients who were admitted to the hospital with acute heart failure 
exacerbation. There were no other demographic factors that were associated with early 
tracheostomy. When the two groups were compared using propensity score matching, they 
did not differ from each other in in-hospital mortality, but clearly showed that early 
tracheostomy was associated with lower total hospital length of stay. 
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INTRODUCTION 
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data 
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was 
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That 
number is anticipated to increase 46% from 2012 to 2030, which can result in more than 8 
million people older than 18 years of age with heart failure. 1  One in nine deaths has heart 
failure on the death certificates, according to the National Center for Health Statistics in 
2013. 2  Acute exacerbation of heart failure may result in acute respiratory failure, which 
requires mechanical ventilator support. Despite supportive management, patients can fail 
extubation of the endotracheal tube and need a tracheostomy to continue mechanical 
ventilator support.   
Tracheostomy usually is done to minimize the mechanical trauma to the larynx or trachea, 
facilitate the weaning process, or protect the airway for a long time. Predictors of 
tracheostomy have been mostly reported in trauma or surgical patients, but it has not been 
studied among patients with acute respiratory failure from acute heart failure exacerbation. 
Also, there has not been a study to compare the outcomes of early tracheostomy in patients 
with acute heart failure exacerbation. The purpose of this study is to identify predictors of 
early tracheostomy (<7 days after intubation) and compare the clinical and economic 
outcomes between the two groups (early tracheostomy and late tracheostomy) among 
patients who were intubated from acute heart failure exacerbation nationwide from 2005 to 
2014. 
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METHODS 
Study subjects 
We conducted a retrospective cohort study using publically accessible national survey data, 
National Inpatient Sample (NIS) from 2005 to 2014. NIS is the largest all-payer inpatient 
care database in the United States, which is developed by the Healthcare Cost and Utilization 
Project (HCUP) 44  NIS is designed to be representative of all non-federal acute care inpatient 
admissions in the United States, and it can approximate a 20 percent stratified sample of 
discharges nationwide. From the NIS dataset, patients who are older than 17 were included 
for the current study. Then, patients who were admitted with acute heart failure were selected 
using ICD-9-CM code. NIS data provides total 30 ICD-9-CM codes. If any of the codes for 
"acute" heart failure, 428.21 (acute systolic health failure), 428.23 (acute on chronic systolic 
heart failure), 428.31 (acute diastolic heart failure), 428.33 (acute on chronic diastolic heart 
failure), 428.41 (acute combined systolic and diastolic heart failure) and 428.43 (acute on 
chronic combined systolic and diastolic heart failure) was listed for the first five diagnosis 
codes, that visit was considered as heart failure acute exacerbation related admission.  We 
used the first five diagnosis codes out of thirty diagnosis codes, since the diagnosis codes 
already had "acute" components in the diagnosis, and tried to minimize the chances of 
missing samples. Then, patients who underwent intubation were selected using ICD-9-CM 
codes, 96.04 (Insertion of the endotracheal tube) and 96.05 (other intubation of respiratory 
tract). Also, if the patient had any of the code for "tracheostomy," 31.1 (temporary 
tracheostomy), 31.2 (permanent tracheostomy), 31.21 (mediastinal tracheostomy) or 31.29 
(other permanent tracheostomy), then the case was selected. Early tracheostomy was defined 
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if the tracheostomy was performed within 7 days after intubation date. Those who underwent 
major therapeutic surgery based on the classification from HCUP were excluded, using 
ICD9-CM codes. 45   
Statistical Analysis 
Predictors of early and late tracheostomy were evaluated by multivariate logistic regression. 
Co-variables to be used for multivariate logistic regressions are age, sex, race, payers, 
location of the hospital (urban vs. rural) and comorbidities (coronary arterial disease, 
hypertension, cerebrovascular disease, diabetes mellitus, peripheral arterial disease, chronic 
obstructive pulmonary disease, cancer, liver disease, pneumonia). Comorbidities were 
selected from the literature using NIS dataset assessing a cardiologic procedure and 
additional significant systemic disorders. 52  Comorbidities were identified using relevant 
ICD-9 CM diagnosis code and Clinical Classification Software (CCS) category provided by 
HCUP from the 30 diagnosis codes, which were documented at the time of discharge. 45  
Survey (svy) commands were used to account for the stratified sampling design of the NIS. 
47,59  
Then, in order to assess various clinical outcomes of early tracheostomy, total hospital length 
of stay, hospital mortality, complication, and decannulation rate were compared between the 
two groups (early tracheostomy group and late tracheostomy group) using a propensity score 
matching. Propensity score matching is a statistical method allowing an observational study 
to estimate the effect of an intervention by controlling the covariates in a way analogous to a 
randomized trial. 50,51  Then a matched pair with similar propensity scores is identified, and 
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the researchers compare the effect of the intervention using the selected pair. In this study, 
we used nearest neighbor 1:1 matching method using the propensity score of being assigned 
to early tracheostomy to identify a matched pair. Co-variables to be used to calculate the 
propensity score are age, sex, race, payers, location of the hospital (urban vs rural) and 
comorbidities (coronary arterial disease, hypertension, cerebrovascular disease, diabetes 
mellitus, peripheral arterial disease, chronic obstructive pulmonary disease, cancer, liver 
disease, pneumonia), which were used for previous multivariate logistic regression. After 
propensity score matching, logistic and linear regression analysis was used to compare the 
mortality, complications, decannulation and total hospital length of stay.   
RESULT 
Predictors of early tracheostomy among patients with acute heart failure exacerbation 
We estimated the odds ratio (OR) of getting early tracheostomy with various co-variables 
(Table 1).   
Among various co-variables, coronary artery disease, pneumonia, and liver disease had a 
significant association with the early tracheostomy, meaning patients with coronary artery 
disease, pneumonia, and liver disease are less likely to receive early tracheostomy (OR 0.79, 
0.63 and 0.64 respectively). Otherwise, there were no significant  
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Table 1. Odds ratio of demographic and clinical characteristics for early tracheostomy 
 Odds ratio 95% CI p-value 
Age 1.00 0.99, 1.00 0.583 
Sex Female 0.93 0.75, 1.15 0.522 
Insurance Private  Reference  0.824 
Medicare/Medicaid 0.86 0.63, 1.19 
Self pay 1.03 0.56, 1.91 
Other 0.91 0.43, 1.90 
Hospital location Urban 1.05 0.12, 1.42 0.735 
Race White Reference  0.644 
Black 1.10 0.86, 1.40 
Hispanic 1.03 0.69, 1.53 
Asian 0.85 0.32, 2.22 
Native American 2.52 0.80, 7.89 
Other 1.18 0.67, 2.06 
Comorbidities Coronary arterial disease 0.79 0.63, 0.98 0.034 
Hypertension 1.17 0.92, 1.47 0.200 
Cerebrovascular disease 1.28 0.91, 1.77 0.165 
Diabetes mellitus 1.12 0.91, 1.39 0.291 
Peripheral arterial disease 0.71 0.43, 1.17 0.174 
Chronic obstructive pulmonary disease 1.12 0.91, 1.39 0.281 
Cancer 1.36 0.99, 1.88 0.059 
Chronic kidney disease 0.87 0.69, 1.09 0.230 
Liver disease 0.64 0.44, 0.95 0.026 
Pneumonia 0.63 0.51, 0.79 <0.001 
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demographic differences in getting early tracheostomy among patients who are admitted with 
acute heart failure exacerbation.  
Early tracheostomy and its clinical outcomes 
After propensity score matching, a matched cohort was used for analysis to assess the 
association between the early tracheostomy and various clinical outcomes, total hospital 
length of stay, in-hospital mortality, complication, and decannulation. Table 2 shows the 
characteristics of covariates before and after matching and table 3 shows the comparison of 
the outcomes between the two groups. Early tracheostomy was not significantly associated 
with in-hospital mortality (OR 0.91, p-value 0.676), or decannulation (OR 2.01, p-value 
0.571). However, early tracheostomy was associated with a higher likelihood of having a 
complication from tracheostomy with OR 2.08 (p-value 0.044). Early tracheostomy was also 
associated with less total hospital length of stay with coefficient factor -6.50 (p-value 0.000) 
from linear regression model. 
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Table 2. Characteristics of covariates before and after matching 
 Before Match Matched pair 
 Early 
tracheostomy 
N=464 
Late 
tracheostomy 
N=3,234 
p-value Early 
tracheostomy 
N=329 
Late 
tracheostomy 
N=329 
p-value 
Age (year) 66.25 66.88 0.342 66.20 66.772 0.537 
Sex (%) 52.37 52.94 0.819 52.24 51.53 0.837 
Non-white (%) 42.96 40.31 0.296 43.29 48.00 0.169 
Non-public 
insurance (%) 
31.47 31.17 0.897 30.82 33.18 0.463 
Urban hospital (%) 84.84 84.24 0.744 85.41 84.24 0.744 
Coronary artery 
disease (%) 
37.50 41.47 0.104 36.94 34.35 0.431 
Hypertension (%) 62.50 57.85 0.058 63.29 60.47 0.397 
Cerebrovascular 
disease (%) 
11.42 8.94 0.084 11.06 11.77 0.747 
Diabetes mellitus 
(%) 
43.89 39.21 0.130 43.29 43.29 >0.99 
Peripheral arterial 
disease (%) 
4.31 5.69 0.224 4.05 4.56 0.605 
Chronic obstructive 
pulmonary disease 
(%) 
40.52 38.06 0.310 40.47 45.65 0.128 
Cancer (%) 12.72 9.83 0.055 12.94 10.82 0.341 
Chronic kidney 
disease (%) 
32.76 33.09 0.889 32.94 32.94 >0.99 
Liver disease (%) 7.76 10,48 0.069 7.294 6.118 0.494 
Pneumonia (%) 5.95 75.51 <0.001 66.59 69.65 0.339 
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Table 3. Result from regression models for clinical outcomes of early tracheostomy using the 
matched cohort. 
 Odds Ratio p-value 
In-hospital mortality 0.91 0.676 
Complication from tracheostomy 2.08 0.044 
Decannulation 2.00 0.571 
 Coefficient factor  
Total hospital length of stay -6.5 <0.001 
 
DISCUSSION 
The current study assessed the predictors of early tracheostomy among patients who were 
admitted with acute heart failure exacerbation. The results showed that coronary arterial 
disease, liver disease, and pneumonia are related to lower odds ratio of getting the early 
tracheostomy with odds ratio of 0.79, 0.64 and 0.63, respectively. However, there is no other 
demographic factor that is significantly associated with early tracheostomy. There are few 
studies that assessed the predictors of early tracheostomy, and they do not correlate with 
current studies' result. A retrospective study by Brook et al. reported that male gender had a 
high likelihood of getting the early tracheostomy. 40 Another retrospective study by Shaw 
reported that women, black race, Hispanics, and patients with Medicaid were less likely to 
receive the early tracheostomy. 60  The current study did not show any gender or racial 
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differences in getting an early tracheostomy. However, the studies referred above included 
heterogeneous groups, but the current study only included patients with acute heart failure 
exacerbations, which may explain the different results from the other studies. Among the 
comorbidities, liver disease and pneumonia could be the complications of prolonged illness 
or shock, which could have served as a reason for late tracheostomy at the later stage of 
hospitalization course, explaining less likelihood to get an early tracheostomy. Coronary 
arterial disease is one of the major comorbidities related to heart failure, and its presence 
might have delayed the decision of tracheostomy since it could prompt the physician to 
pursue additional curative intervention for coronary arterial disease during that 
hospitalization. 
Another objective of the current study was to compare clinical outcomes between the two 
groups. There was no difference in in-hospital mortality and decannulation rate between the 
two groups. However, a complication from the tracheostomy was more common in early 
tracheostomy group (OR 2.08 with p-value 0.044). Total hospital length of stay was 
significantly different, and the early tracheostomy group had 6.5 shorter days than the late 
tracheostomy group. (p-value <0.001). The mortality benefit from early tracheostomy has 
been controversial based on multiple studies. However, a recent systemic review and meta-
analysis by Liu et al. reported that early tracheostomy has lower short-term mortality. 31  The 
current study did show less mortality in early tracheostomy group, but it was not statistically 
significant. Complication from the tracheostomy was higher in early tracheostomy group in 
our study. It is not consistent with the result from other studies. Young et al. reported a lower 
complication rate in early tracheostomy group (5.5% in early tracheostomy group and 7.8% 
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in late tracheostomy group), without statistical significance. Further studies are warranted to 
compare the complication rates between the two groups since the results are not consistent 
between the two studies.  Early tracheostomy clearly showed a shorter total length of stay in 
the hospital, shortening the length of stay by 6.5 days. Most of the previous studies 
comparing early and late tracheostomy have mainly focused on the cost and length of stay in 
the ICU, not the total hospital stay. 37,61  Rumbak et al. showed that early tracheostomy could 
reduce the ICU stay up to 11.40 days. 37  Our study did not look into the ICU stay because of 
the limitation of the information from the original dataset. However, it did confirm that the 
early tracheostomy reduces the length of stay in the hospital.  
The current study has several limitations. First, this study used a discharge dataset and 
conducted a retrospective cohort study. Although potential confounders were adjusted 
through propensity score matching and multivariate logistic regression, selection bias cannot 
be completely eliminated. Choice of timing for tracheostomy can be affected by multiple 
factors including the clinician's preference, the patient's decision, hospital policy or other co-
existing clinical conditions, which we were not able to obtain from the dataset. However, the 
result of propensity score matching actually showed that the two groups did not much differ 
each other even before the matching.  
Second, we identified acute heart failure exacerbation cases using the first five diagnosis 
codes from total 30 diagnosis codes, rather than only the first diagnosis, We used this method 
because the etiology of respiratory failure requiring intubation could be placed in second or 
third place of the diagnosis list, and we wanted to maximize our sample size without missing 
a case. However, it is also possible that there might be another clinical condition, which 
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required intubation, such as chronic obstructive pulmonary disease, pneumonia, trauma or 
surgical conditions. If it is the case, then our study group might be somewhat heterogeneous. 
However, we tried to adjust such conditions through multivariate regression and propensity 
score matching. We also excluded patients who underwent therapeutic surgery to avoid this 
problem. 
Lastly, we did not have information regarding the severity of heart failure. The severity of 
heart failure affects the clinical courses and prognosis, which plays a significant role in the 
decision of tracheostomy. However, we do not have such information, so we could not 
stratify the patients according to the severity of the primary disease. 
CONCLUSION 
Despite several limitations, the current study has several strengths. It used a nationally 
representative data to evaluate the predictors of early tracheostomy in patients with a specific 
condition, acute heart failure exacerbation. Patients with coronary artery disease, liver 
disease, and pneumonia were associated lower likelihood to receive early tracheostomy (<7 
days after intubation) rather than late tracheostomy among patients who were admitted to the 
hospital with acute heart failure exacerbation. There were no other demographic factors that 
were associated with early tracheostomy. When the two groups were compared using 
propensity score matching, they did not differ from each other in in-hospital mortality, but 
clearly showed that early tracheostomy was associated with lower total hospital length of 
stay.	
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ABSTRACT 
Background 
The optimal time of tracheostomy among patients with acute heart failure exacerbation has 
been controversial. Several studies have proposed economic benefit from the early 
tracheostomy, but no research has focused only on those with acute heart failure 
exacerbation. The purpose of this study was an economic evaluation of early and late 
tracheostomy among those who developed respiratory failure with acute congestive heart 
failure exacerbation using average and incremental costs with the outcome of total hospital 
length of stay and post-procedure length of stay. 
Methods 
We conducted an economic evaluation of early tracheostomy for the outcome of total 
hospital length of stay and post-procedural length of stay among patients who are admitted 
with acute heart failure exacerbation. We used mortality, costs, length of stay, and post-
procedural length of stay from an observational study using National Inpatient Sample data 
from 2005 to 2014.  
Results 
The early tracheostomy dominates the late tracheostomy with the outcome of total hospital 
length of stay and post-procedural length of stay with lower cost and higher effectiveness. 
The incremental cost-effectiveness ratio is actually negative, that is, it costs $3,492.65 dollars 
for each additional day in the hospital for late tracheostomy versus early tracheostomy. 
Furthermore, the average cost per effectiveness is higher in late tracheostomy group 
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($2,743.43) than in the early group ($2,420.82). The average post-procedural cost per 
effectiveness was $2,440.17 in late tracheostomy group and $2,591.03 in the early group. 
However, the incremental cost-effectiveness ratio is again negative, at $2,032.67 dollars per 
extra day in the hospital after the procedure. 
Conclusions 
The current study showed that early tracheostomy is more cost-effective with the outcome of 
total hospital length of stay and post-procedural length of stay than late tracheostomy among 
patients with acute heart failure exacerbation. 
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INTRODUCTION 
Heart failure is one of the leading causes of high morbidity and mortality. Based on the data 
from National Health and Nutrition Examination Survey (NHANES) 2009 to 2012, it was 
estimated that total 5.7 million Americans older than 20 years of age had heart failure. That 
number is anticipated to increase by 46% from 2012 to 2030, which can result in more than 8 
million people older than 18 years of age with heart failure. 1  Considering the development 
and implementation of life-prolonging interventions along with the growing elderly 
population, the number of individuals with heart failure will be significantly increased, which 
will also increase the cost of heart failure. 7,8  Hence, the economic burden for society is an 
issue. A study using 10-year data from the National Medical Expenditure Panel Survey 
(2002-2011) showed that individuals with heart failure had 4 times higher yearly expenditure 
($23,854) compared to those without heart failure ($5,511) and the single largest driving 
component of this increase was inpatient costs ($11,318). 8  Acute heart failure exacerbation 
is one of the leading causes of hospitalization among patients with heart failure. It is also 
potentially fatal, which may result in acute respiratory failure requiring intubation and 
admission to the intensive care unit and mechanical ventilator care. Despite ongoing 
treatment for congestive heart failure, not all the patients can be weaned off the ventilator. In 
such cases, the health care providers should consider tracheostomy. 11,14  Tracheostomy is 
considered to be beneficial to be more comfortable for the patients, requires less sedation, 
and provides more stable airway compared to an endotracheal tube, but it still carries several 
complications including bleeding, hypoxia, structural damage or cardiopulmonary arrest. 11  
Hence, the optimal time for tracheostomy with the goal of getting extubated, and also to 
prevent complications from prolonged intubation and to secure more stable airway, has been 
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controversial. 15,20  Considering the significant economic burden of acute heart failure 
exacerbation and subsequent respiratory failure requiring intubation, a strategy to determine 
the optimal timing of tracheostomy should be investigated. Liu et al. reported cost-
effectiveness of early versus late tracheostomy with the outcome of tracheostomy prevented 
and it showed that early tracheostomy could be more cost-effective with a willingness to pay 
threshold of $80,000 per tracheostomy avoided. 30  Other studies have shown that early 
tracheostomy may provide less mortality and fewer healthcare resources utilization. 
However, most of the studies included heterogeneous clinical conditions in their outcome 
assessment. Furthermore, to the best of our knowledge, studies comparing early and late 
tracheostomy for patients with acute respiratory failure due to congestive heart failure are 
lacking.  
The purpose of this study was an economic evaluation of early and late tracheostomy among 
those who developed respiratory failure with acute congestive heart failure exacerbation 
using average and incremental costs with the outcome of total hospital length of stay and 
post-procedure length of stay. The result of the study will provide evidence to assist both 
clinicians and hospital administrator in determining the most efficient care strategy for 
managing patients with respiratory failure from acute heart failure exacerbation requiring 
ventilator assistance.  
METHODS 
We used a publically accessible national survey data, National Inpatient Sample (NIS) from 
2005 to 2014 to obtain cost and effectiveness data for economic evaluation. NIS is the largest 
all-payer inpatient care database in the United States, which is developed by the Healthcare 
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Cost and Utilization Project (HCUP) 44  It allows the researchers to assess national estimates 
of clinical and resource-use information such as diagnosis, procedures, morbidity codes, 
patient’s demographic characteristics, hospital characteristics, expected payment source, total 
charges, length of stay, and severity and comorbidity measures from hospital inpatient stays 
in the United States. It is drawn from all states participating in HCUP and represents more 
than 97 percent of the U.S. population. 
Effectiveness was defined total hospital length of stay and post-procedure length of stay. 
Both average and incremental cost-effectiveness ratios (ICER) were used for the economic 
evaluation. With the effectiveness of hospital length of stay, ICER was calculated by 
dividing incremental total hospital cost by incremental length of stay. With the effectiveness 
of post-procedural length of stay, ICER was obtained using incremental post-procedural 
hospital cost and incremental post-procedural length of stay.  
The number of early and late tracheostomies, mortality for each intervention, the costs and 
the length of stay in the hospital came from the current dataset for the base case analysis 
(Table 1). The mortality was obtained from a comparative analysis using propensity score 
matching. From the NIS database from 2004 to 2015, patients who were admitted with the 
diagnosis of acute heart failure exacerbation were selected using ICD-9-CM codes. Patients 
who were younger than 18 years old and who received therapeutic surgery were excluded 
from the study. Then a matched pair, early tracheostomy group versus late tracheostomy 
group, was obtained using propensity score matching adjusting covariates including age, sex, 
race, payers, location of the hospital (urban vs rural) and comorbidities (coronary arterial 
disease, hypertension, cerebrovascular disease, diabetes mellitus, peripheral arterial disease, 
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chronic obstructive pulmonary disease, cancer, liver disease, pneumonia). We used nearest 
neighbor 1:1 matching method. Early tracheostomy was defined if the patient received 
tracheostomy within 7 days. Then, the mortality rate from each group was obtained from the 
matched pair. 
Other probabilities for the economic evaluation came from a literature review. The mean 
costs and length of stay for each node were obtained using discharge weight (variable 
DISCWT), provided by AHRQ. 46-48  Total hospital cost was provided by the dataset, but the 
post-procedural cost was calculated by multiplying the post-procedural length of stay by 
daily cost, and the daily cost was calculated by dividing the total hospital cost by the total 
length of stay. 
If one intervention shows higher effectiveness and lower cost, that intervention could be said 
to dominate another one. 62  For example, if one intervention requires less total cost, but 
resulted in a shorter stay in the hospital, then we would state that that intervention dominates 
another one. The time horizon was during the admission, and discounting was not applied 
because of short time horizon. This study was conducted from the U.S. health care all-payers 
perspective. All costs were adjusted to 2014 U.S dollars using consumer price index.  
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Table 1. Model parameters for probabilities 
Variables Value  Distribution Source Range 
Probabilities  
Intra-operation mortality 0.004 β Halum et al. 63  (0~1) 
Early tracheostomy, a complication related 
to tracheostomy 
0.054 β Young et al. 33  (0~1)  
Late tracheostomy, a complication related 
to tracheostomy 
0.075 β Young et al. 33  (0~1) 
Early tracheostomy, decannulation  0.51 β Koch et al. 38  (0~1) 
Late tracheostomy, decannulation 0.33 β Koch et al. 38  (0~1) 
Early tracheostomy, mortality 0.14 β Present study (0-1) 
Late tracheostomy, mortality 0.15 β Present study (0-1) 
Variables Value  Distribution Source Range 
Costs 
Early tracheostomy, cost for each node ($)  γ Present study ±25% 
Late tracheostomy, cost for each node ($)  γ Present study ±25% 
Effects  
Total hospital length of stay for each node 
(days) 
 NA Present study NA 
Post-procedural length of stay days for 
each node (days)  
 NA Present study NA 
 
Sensitivity analysis was conducted on probabilities and costs, using probabilistic sensitivity 
analysis. The minimum value and maximum values were estimated 25% lower and 25% 
	 70	
more than the mean value, respectively. There were several nodes where the dataset did not 
have any case, so values (cost and effectiveness) of those nodes were substituted from the 
neighboring branches. Those nodes were intra-operation mortality in early tracheostomy 
(EarlyNosurvive), those with complication from the tracheostomy, and decannulated but died 
in the hospital in early tracheostomy group (EarlySurviveCompDecanDeath), those with 
complication from the tracheostomy, decannulated and discharged from the hospital alive in 
early tracheostomy group EarlySurviveCompLive), those without complication from the 
tracheostomy, and decannulated but died in the hospital in early tracheostomy group 
(EarlySurviveNocompDecDeath), and those with complication from the tracheostomy, and 
decannulated but died in the hospital in late tracheostomy group 
(LateSurviveCompDecanDeath). The range of the probabilities was 0 to 1. A Tornado 
diagram was utilized to determine the factors that had the most impact on the choice of 
tracheostomy. Probabilistic sensitivity analysis was conducted using the distribution assigned 
to the probabilities and costs, using a willingness to pay threshold, and the cost-effectiveness 
acceptability curve was plotted. Stata/IC 14.2 was used to estimate the cost and effectiveness 
from the NIS database, and TreeAge Pro program was used to construct the decision tree 
model and calculate both ratios. 
RESULT 
Economic evaluation with the outcome of total hospital length of stay 
Figure 1 shows the decision tree from the economic evaluation with the outcome of the total 
hospital length of stay between the early tracheostomy and late tracheostomy. The first 
economic evaluation was conducted with the outcome of the total hospital length of stay. The 
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result showed that early tracheostomy dominates late tracheostomy with lower total hospital 
cost and shorter total hospital length of stay (Table 2 and Figure 2).  The incremental cost-
effectiveness ratio is actually negative, that is, it costs $3,492.65 dollars for each additional 
day in the hospital for late tracheostomy versus early tracheostomy. Furthermore, the average 
cost per effectiveness is higher in late tracheostomy group ($2,743.43) than in the early group 
($2,420.82).  
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Figure 1. D
ecision tree for the econom
ic evaluation w
ith the outcom
e of total hospital length of stay  
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Figure 2. Cost-effectiveness analysis graph with outcome total hospital length of stay 
 
 
Table 2. Cost-effectiveness analysis using outcome total hospital length of stay 
Strategy Cost Incr Cost Eff Incr Eff Incr C/E Average C/E 
Early tracheostomy 54,489.20  22.51   2,420.82 
Late tracheostomy 88,340.84 33,851.64 32.20 -9.69 -3,492.65 2,743.43 
*Incr : Incremental, Eff: Effectiveness, C: Cost, E: Effectiveness 
For sensitivity analysis, we performed a tornado diagram and probabilistic sensitivity 
analysis. Figure 3 shows the decision tree for the sensitivity analysis. We assumed that all the 
probabilities have beta distribution and costs have gamma distribution. For range, if the 
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confidence interval is known from the literature, we used them, but if not, we used high as 1 
and low as 0 for probability, and ±25% of the average cost.  
From the tornado gram, the probability of tracheostomy-related complication in early 
tracheostomy group had the highest impact on ICER resulting in a range from -3,195.03 to 
4,976.14 (Figure 4).  Then, we sampled 1000 observations and formulated a cost-
effectiveness acceptability curve. Even after the sensitivity analysis, early tracheostomy still 
dominates for the effectiveness of less total length of stay in the hospital, and cost-
effectiveness acceptability curves do not cross over (Figure 5).  
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Figure 3. D
ecision tree for the sensitivity analysis w
ith the outcom
e of total hospital length of stay 
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Figure 4. Tornado diagram of ICER using outcome total hospital length of stay 
 
Figure 5. Cost-effectiveness acceptability curve with outcome total hospital length of stay 
 
		 77	
Economic evaluation with the outcome of post-procedural hospital length of stay 
The second economic evaluation was conducted with the outcome of the post-procedural 
length of stay, meaning the length of stay after tracheostomy. Figure 6 shows the decision 
tree with the outcome of post-procedural length of stay. The result showed that early 
tracheostomy again dominates late tracheostomy with lower post-procedural hospital cost 
and shorter post procedural hospital length of stay (Table 3 and Figure 7). The average cost 
per effectiveness was $2,440.17 in late tracheostomy group and $2,591.03 in the early group. 
However, the incremental cost-effectiveness ratio is again negative, at $2,032.67 dollars per 
extra day in the hospital after the procedure. 
Table 3. Cost-effectiveness analysis using outcome post-procedural length of stay 
Strategy Cost Incr Cost Eff Incr Eff Incr C/E C/E 
Early tracheostomy 46,366.49 0 17.89 0 0 2,591.03 
Late tracheostomy 59,832.38 13,465.89 24.52 -6.62 -2,032.67 2,440.17 
*Incr : Incremental, Eff: Effectiveness, C: Cost, E: Effectiveness 
Again, for sensitivity analysis, we performed a tornado diagram and probabilistic sensitivity 
analysis. We assumed that all the probabilities have beta distribution and costs have gamma 
distribution. For range, if the confidence interval is known from the literature, we used them, 
but if not, we used high as 1 and low as 0 for probability, and ±25% of the average cost. 
From the tornado gram, the probability of complication after tracheostomy among patients 
who underwent late tracheostomy had the highest impact on ICER resulting in a range from -
7,075.09 to -1,561.15 (Figure 9).  Then, we sampled 1000 observations and formulated a 
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cost-effectiveness acceptability curve. Even after the sensitivity analysis, again, early 
tracheostomy still dominates for the effectiveness of less post-procedural length of stay in the 
hospital, and cost-effectiveness acceptability curves do not cross over (Figure 10).
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Figure 6. D
ecision tree w
ith the outcom
e of post-procedural length of stay 
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Figure 7. Cost-effectiveness analysis graph with outcome post-procedural length of stay 
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Figure 8. D
ecision tree for sensitivity analysis w
ith outcom
e of post-procedural length of stay 
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Figure 9. Tornado diagram of ICER using outcome post-procedural length of stay 
 
Figure 10. Cost-effectiveness acceptability curve using the outcome post procedural length of 
stay 
	
		 83	
DISCUSSION 
The current study evaluated the cost-effectiveness of early tracheostomy using the outcome 
of total hospital length of stay, and post-procedural length of stay. For both outcomes, early 
tracheostomy dominated late tracheostomy. It had a lower cost with less hospital length of 
stay. Even after sensitivity analysis, early tracheostomy remains to dominate late 
tracheostomy with a willingness to pay up to $100,000. 
We particularly chose the length of stay as the outcome of the economic evaluation since 
previous studies have shown very controversial results for mortality differences between 
early and late tracheostomy, but somewhat consistent results for less health care utilization in 
early tracheostomy group. Furthermore, from our own analysis of NIS dataset, mortality rates 
from the two interventions were incorporated into the decision tree as probabilities and 
reflected the final economic analysis. 
To the best of our knowledge, there has been only one economic evaluation study assessing 
early tracheostomy. Liu et al. reported cost-effectiveness of early versus late tracheostomy 
with the outcome of tracheostomy prevented and it showed that early tracheostomy could be 
more cost-effective with a willingness to pay threshold of $80,000 per tracheostomy avoided. 
30  However, this study focused on the cost-effectiveness per tracheostomy avoided, not 
health care utilization such as length of stay. Several other studies have reported less health 
care resources utilization among early tracheostomy group with various medical or surgical 
conditions, proposing less intensive care unit stay or shorter ventilation dependent days. 25,27  
However, the current study is the first study to perform cost-effectiveness analysis using 
outcomes of hospital length of stay among patients who are admitted with acute heart failure 
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exacerbation. Furthermore, the cost and effectiveness information came from real patients 
data, rather than literature review or expert opinion, and it makes the result of evaluation 
more credible.   
However, the current study holds several limitations. First, even though the mortality, cost, 
and effectiveness were derived from real patients' data, the result is still from a retrospective 
cohort study, not a randomized controlled study. The information still could be confounded 
by selection bias. However, we tried to reduce its effect by sensitivity analysis. When 
performing sensitivity analysis, for the probability we used the widest range possible, from 0 
to 1, and still, the result showed that early tracheostomy dominates the late tracheostomy. 
Second, based on the decision tree, each node should have its own cost and effectiveness 
from the database, but some nodes did not have any sample from the database since the 
sample size was small. In such cases, we used the cost and effectiveness from the 
neighboring nodes for sensitivity analysis. Hence, the tree does not reflect the real clinical 
situation, but we tried to overcome it through sensitivity analysis.  
Last, for the economic analysis with the outcome of post-procedural length of stay, we used 
the estimated cost that was calculated by the daily cost ((Total hospital cost/total length of 
stay) * post-procedural length of stay). It may not reflect the actual cost after the procedure, 
since the patient care after the procedure may be significantly different. However, due to the 
limitation of the dataset and information availability, we tried to use the best alternative. 
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CONCLUSION 
The current study showed that early tracheostomy is more cost-effective with the outcome of 
total hospital length of stay and post-procedural length of stay than late tracheostomy among 
patients with acute heart failure exacerbation.  
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APPENDIX 
APPENDIX A. Variable values for cost effectiveness analysis with outcome of total hospital 
length of stay 
Name Root Definition 
cEarlyNosurvive  0 
cEarlySurviveCompDecanDeath 0 
cEarlySurviveCompDecanLive 0 
cEarlySurviveCompNodecanDeath 71,984.93 
cEarlySurviveCompNodecanLive 66,896.56 
cEarlySurviveNocompDecanDeath 0 
cEarlySurviveNocompDecanLive 59,604.39 
cEarlySurviveNocompNodecanDeath 67,579.37 
cEarlySurviveNocompNodecanLive 59,709.12 
cLateNosurvive 44,235.01 
cLateSurviveCompDecanDeath 0 
cLateSurviveCompDecanLive 128,999.90 
cLateSurviveCompNodecanDeath 114,616.60 
cLateSurviveCompNodecanLive 97,910.96 
cLateSurviveNocompDecanDeath 91,305.28 
cLateSurviveNocompDecanLive 90,299.62 
cLateSurviveNocompNodecanDeath 105,054.60 
cLateSurviveNocompNodecanLive  82,785.89 
eEarlyNosurvive 0 
eEarlySurviveCompDecanDeath 0 
eEarlySurviveCompDecanLive 0 
eEarlySurviveCompNodecanDeath 21.91 
eEarlySurviveCompNodecanLive 21.64 
eEarlySurviveNocompDecanDeath 0 
eEarlySurviveNocompDecanLive 23.33 
eEarlySurviveNocompNodecanDeath 23.30 
eEarlySurviveNocompNodecanLive 23.23 
eLateNosurvive 12.20 
eLateSurviveCompDecanDeath 0 
eLateSurviveCompDecanLive 38.46 
eLateSurviveCompNodecanDeath 42.08 
eLateSurviveCompNodecanLive 32.83 
eLateSurviveNocompDecanDeath 43 
eLateSurviveNocompDecanLive 38.41 
eLateSurviveNocompNodecanDeath 34.75 
eLateSurviveNocompNodecanLive 29.64 
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APPENDIX B. Variable values for PSA with outcome of total hospital length of stay 
Name Root Definition 
cEarlyNosurvive  44,235.01 
cEarlySurviveCompDecanDeath 128,999.90 
cEarlySurviveCompDecanLive 128,999.90 
cEarlySurviveCompNodecanDeath 71,984.93 
cEarlySurviveCompNodecanLive 66,896.56 
cEarlySurviveNocompDecanDeath 59,604.39 
cEarlySurviveNocompDecanLive 59,604.39 
cEarlySurviveNocompNodecanDeath 67,579.37 
cEarlySurviveNocompNodecanLive 59,709.12 
cLateNosurvive 44,235.01 
cLateSurviveCompDecanDeath 128,999.90 
cLateSurviveCompDecanLive 128,999.90 
cLateSurviveCompNodecanDeath 114,616.60 
cLateSurviveCompNodecanLive 97,910.96 
cLateSurviveNocompDecanDeath 91,305.28 
cLateSurviveNocompDecanLive 90,299.62 
cLateSurviveNocompNodecanDeath 105,054.60 
cLateSurviveNocompNodecanLive 82,785.89 
eEarlyNosurvive 12.20 
eEarlySurviveCompDecanDeath 38.46 
eEarlySurviveCompDecanLive 38.46 
eEarlySurviveCompNodecanDeath 21.91 
eEarlySurviveCompNodecanLive 21.64 
eEarlySurviveNocompDecanDeath 23.33 
eEarlySurviveNocompDecanLive 23.33 
eEarlySurviveNocompNodecanDeath 23.30 
eEarlySurviveNocompNodecanLive 23.23 
eLateNosurvive 12.20 
eLateSurviveCompDecanDeath 38.46 
eLateSurviveCompDecanLive 38.46 
eLateSurviveCompNodecanDeath 42.08 
eLateSurviveCompNodecanLive 32.83 
eLateSurviveNocompDecanDeath 43.00 
eLateSurviveNocompDecanLive 38.41 
eLateSurviveNocompNodecanDeath 34.75 
eLateSurviveNocompNodecanLive 29.64 
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APPENDIX C. Variable values for cost effectiveness analysis with outcome of post 
procedural length of stay 
Name Root Definition 
cEarlySurviveCompDecanDeath 0 
cEarlySurviveCompDecanLive 0 
cEarlySurviveCompNodecanDeath 57,102.66 
cEarlySurviveCompNodecanLive 58,334.76 
cEarlySurviveNocompDecanDeath 0 
cEarlySurviveNocompDecanLive 50,796.8 
cEarlySurviveNocompNodecanDeath 56,880.93 
cEarlySurviveNocompNodecanLive 50,320.07 
cLateSurviveCompDecanDeath 0 
cLateSurviveCompDecanLive 70,357.85 
cLateSurviveCompNodecanDeath 63,794.57 
cLateSurviveCompNodecanLive 63,886.94 
cLateSurviveNocompDecanDeath 61,577.98 
cLateSurviveNocompDecanLive 85,435.52 
cLateSurviveNocompNodecanDeath 62,135.93 
cLateSurviveNocompNodecanLive 46,248.49 
eEarlySurviveCompDecanDeath 0 
eEarlySurviveCompDecanLive 0 
eEarlySurviveCompNodecanDeath 18.05 
eEarlySurviveCompNodecanLive 18.61 
eEarlySurviveNocompDecanDeath 0 
eEarlySurviveNocompDecanLive 19.67 
eEarlySurviveNocompNodecanDeath 19.99 
eEarlySurviveNocompNodecanLive 19.94 
eLateNosurvive 0 
eLateSurviveCompDecanDeath 0 
eLateSurviveCompDecanLive 21.69 
eLateSurviveCompNodecanDeath 26.64 
eLateSurviveCompNodecanLive 21.08 
eLateSurviveNocompDecanDeath 29 
eLateSurviveNocompDecanLive 41.30 
eLateSurviveNocompNodecanDeath 21.15 
eLateSurviveNocompNodecanLive 17.05 
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APPENDIX D. Variable values for PSA with outcome of post-procedural length of stay 
Name Root Definition 
cEarlySurviveCompDecanDeath 70,357.85 
cEarlySurviveCompDecanLive 70,357.85 
cEarlySurviveCompNodecanDeath 57,102.66 
cEarlySurviveCompNodecanLive 58,334.76 
cEarlySurviveNocompDecanDeath 50,796.80 
cEarlySurviveNocompDecanLive 50,796.80 
cEarlySurviveNocompNodecanDeath 56,880.93 
cEarlySurviveNocompNodecanLive 50,320.07 
cLateSurviveCompDecanDeath 70,357.85 
cLateSurviveCompDecanLive 70,357.85 
cLateSurviveCompNodecanDeath 63,794.57 
cLateSurviveCompNodecanLive 63,886.94 
cLateSurviveNocompDecanDeath 61,577.98 
cLateSurviveNocompDecanLive 85,435.52 
cLateSurviveNocompNodecanDeath 62,135.93 
cLateSurviveNocompNodecanLive 46,248.49 
eEarlySurviveCompDecanDeath 21.69 
eEarlySurviveCompDecanLive 21.69 
eEarlySurviveCompNodecanDeath 18.05 
eEarlySurviveCompNodecanLive 18.61 
eEarlySurviveNocompDecanDeath 19.67 
eEarlySurviveNocompDecanLive 19.67 
eEarlySurviveNocompNodecanDeath 19.99 
eEarlySurviveNocompNodecanLive 19.94 
eLateSurviveCompDecanDeath 21.69 
eLateSurviveCompDecanLive 21.69 
eLateSurviveCompNodecanDeath 26.64 
eLateSurviveCompNodecanLive 21.08 
eLateSurviveNocompDecanDeath 29 
eLateSurviveNocompDecanLive 41.30 
eLateSurviveNocompNodecanDeath 21.15 
eLateSurviveNocompNodecanLive 17.05 
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